Aug. 4 at 6:53 PM
$MNKD I reckon my hope is that MNKD becomes a drug maker, not just a form of contractor providing a device to allow existing drugs to be administered. Tyvasso and Afrezza are ways to inhale drugs, but the big money is in the drug itself (except for insulin of course which is pretty much a generic at this point.) But if MNKD can make one of the drugs they are working on function, tie it with their inhalation technology, they are golden. Not only do they own the drug, but they own the preferred way to take it that doesn't cause side effects. It will be huge even if the market size isn't. Easy 100 dollar a share company.
